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Daily HIV pre-exposure prophylaxis 
(PrEP) with tenofovir disoproxil 
fumarate-emtricitabine reduced 
Streptococcus and increased 
Erysipelotrichaceae in rectal 
microbiota
Michael P. Dubé1, Sung Yong Park2, Heather Ross2, Tanzy M. T. Love3, Sheldon R. Morris4 & 
Ha Youn Lee2
Daily PrEP is highly effective at preventing HIV-1 acquisition, but risks of long-term tenofovir disoproxil 
fumarate plus emtricitabine (TDF-FTC) include renal decline and bone mineral density decrease in 
addition to initial gastrointestinal side effects. We investigated the impact of TDF-FTC on the enteric 
microbiome using rectal swabs collected from healthy MSM before PrEP initiation and after 48 to 
72 weeks of adherent PrEP use. The V4 region of the 16S ribosomal RNA gene sequencing showed 
that Streptococcus was significantly reduced from 12.0% to 1.2% (p = 0.036) and Erysipelotrichaceae 
family was significantly increased from 0.79% to 3.3% (p = 0.028) after 48–72 weeks of daily PrEP. 
Catenibacterium mitsuokai, Holdemanella biformis and Turicibacter sanguinis were increased within 
the Erysipelotrichaceae family and Streptococcus agalactiae, Streptococcus oralis, Streptococcus mitis 
were reduced. These changes were not associated with host factors including PrEP duration, age, 
race, tenofovir diphosphate blood level, any drug use and drug abuse, suggesting that the observed 
microbiome shifts were likely induced by daily PrEP use. Long-term PrEP resulted in increases 
of Catenibacterium mitsuokai and Holdemanella biformis, which have been associated with gut 
microbiome dysbiosis. Our observations can aid in characterizing PrEP’s side effects, which is likely to 
improve PrEP adherence, and thus HIV-1 prevention.
Truvada, a fixed-dose combination of the nucleoside reverse transcriptase inhibitors (NRTI) tenofovir disoproxil 
fumarate (TDF) plus emtricitabine (FTC), was approved for daily HIV-1 pre exposure prophylaxis (PrEP) in 
2012, and by 2015 more than 79,000 people in US are estimated to have started TDF-FTC for PrEP1. Daily PrEP 
is highly effective at preventing HIV-1 infection, reducing HIV-1 acquisition by over 90% in MSM2. As a key part 
of the national HIV/AIDS strategy, PrEP use is expected to continue to increase, and thus understanding the side 
effects of widespread PrEP adoption is an important task.
In randomized studies in long-term PrEP users, kidney function decline3 and bone mineral density decrease4 
have been reported, which are in concordance with the observations among TDF-treated HIV-infected individu-
als5,6. Renal tubular toxicity of TDF has been suggested as a mechanism for kidney abnormalities7. TDF-induced 
bone mineral density decreases have been explained by osteoblast gene expression changes8 and tubular dysfunc-
tion and resulting phosphaturia9. We may gain further insights on these long-term PrEP side effects by profiling 
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the gut microbiome as the human gut microbiota is reported to be correlated with both chronic kidney disease 
and osteoporosis. Increases in uremic toxins and inflammation among chronic kidney disease patients were in 
part due to the gut microbiome’s role in the fermentation of short-chain fatty acids10. Several studies reported a 
significant association between the intestinal microbiota, calcium absorption, and bone health11,12. As suggested 
from these findings, study of the microbiome profile, in the absence of HIV infection during PrEP, may provide 
an important correlate for addressing long-term side effects attributable to TDF-FTC use.
A direct interaction between a drug and the enteric microbiome has been demonstrated for different classes 
of drugs13–15. Other drugs may also have indirect and unintended antimicrobial activities16. Indeed, a recent 
population-level study found medication to have the greatest influence on gut microbiome composition, compare 
to other covariates such as gender, diet, and health status17.
In this study, we investigated the impact of PrEP on the enteric microbiome using serial specimens collected 
from healthy individuals before initiation of PrEP (baseline) and after 48 to 72 weeks of adherent PrEP use in the 
California Collaborative Treatment Group study 595 (NCT01761643). CCTG 595 was a randomized controlled 
trial in high risk MSM and transgender women to compare the impact of daily text messaging to standard care 
on daily TDF-FTC adherence18. We chose study participants with documented adequate adherence to PrEP and 
these are optimal for investigating the direct impact of daily PrEP on the enteric microbiome profile. By per-
forming next-generation sequencing of the bacterial 16S ribosomal RNA (rRNA) gene, we assessed the relative 
abundance of each family and genus before and after PrEP administration and identified microbiome shifts after 
long-term PrEP. In addition, we conducted long-read next-generation sequencing of bacterial 16S-23S rRNA to 
identify which species are impacted by long-term daily PrEP.
Results
We compared the microbiome composition of 8 study participants’ rectal specimens before PrEP administration 
and after 48 to 72 weeks of adherent PrEP use. Table 1 lists each study participant’s age, race, duration of PrEP use, 
tenofovir diphosphate (TFV-DP) level measured at 48 weeks post PrEP initiation, and any other drug usage and 
abuse. The next-generation sequencing reads of the V4 region of the 16s ribosomal RNA gene were obtained and 
processed as described in Methods. The number of sequencing reads before and after processing are provided in 
Supplementary Table S1.
PrEP-induced changes in the microbiome composition were assessed with two methods. First, we statisti-
cally addressed the impact of PrEP on the microbiome composition using a permutation test. To control for the 
small sample size, we performed a permutation test in which we randomly permuted all specimens’ PrEP status 
(pre-PrEP or post-PrEP) to identify any meaningful differences in the microbiome composition at the family and 
genus levels. An empirical p-value was obtained for each family or genus through 100,000 PrEP status permuta-
tions. We also conducted a paired-permutation test by permuting each individual’s PrEP status and evaluating 
the chance to observe the measured t-statistic, compared to the t-statistic distribution for all possible 28 arrange-
ments. Second, we calculated the log fold change of each family or genus, defined as log2 of the ratio between 
mean abundances after and before PrEP.
Figure 1 plots the abundance of each family and genus from eight subjects before and after PrEP, sorted by the 
empiric p-value obtained from the permutation test. At the family level, the permutation test indicated that the 
abundances of Erysipelotrichaceae and Streptococcaceae were statistically significantly altered with a minimum of 
48 weeks PrEP administration (p = 0.028 and p = 0.039, respectively). Erysipelotrichaceae and Streptococcaceae 
remained significantly different under the paired-permutation test (p = 0.031 and p = 0.039, respectively). 
Pre-PrEP specimens had 0.79% of Erysipelotrichaceae on average, however, its relative abundance was increased 
to 3.3% after PrEP, resulting in a mean log2(fold change) of 2.1. As shown in Fig. 2A, six out of eight partici-
pants showed Erysipelotrichaceae increase after PrEP. On the contrary, relative abundance of Streptococcaceae 
was decreased after PrEP with log2 (fold change) of −3.3. Four participants showed a considerable reduction of 
Streptococcaceae with an over 10 percent decrease.
At the genus level, Streptococcus was significantly reduced after PrEP administration (permutation test, 
p = 0.036 and paired-permutation test, p = 0.035). The average relative abundance of Streptococcus across eight 
study participants was 12.0% before PrEP initiation. However, after 48–72 weeks of daily TDF-FTC, the average 
abundance was reduced to 1.2%. Figure 2B compares the Streptococcus abundance before and after PrEP for each 
of eight study participants. The mean log2(fold change) over eight participants was −3.3 and we observed more 
Participant
PrEP 
Duration Age Race
TFV-DP 
(fmol/punch)
Any 
drug use
Any drug 
abuse
Rectal 
douching
WWS 72 39 Asian 2059 Yes No No
XNT 72 28 White 1755 Yes Yes Yes
WD5 72 52 White 1620 No No Yes
WT9 72 29 White 1447 Yes Yes Yes
XRQ 72 33 White 1417 No No Yes
7RJ 48 22 Multiple 1163 Yes Yes Yes
7FX 60 38 Black 1151 Yes No Yes
7NR 48 37 Multiple 996 Yes No Decline*
Table 1. Demographic and clinical information of 8 PrEP study participants. *Declined to answer.
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than a 10 percent reduction in Streptococcus level in four participants (Fig. 2B). In particular, participant XNT 
showed a reduction from 51% to 1.9%. Within the Streptococcaceae family, Streptococcus was the dominant genus 
(>99%) in all eight participants, resulting in significant shifts at both the family and genus levels. Table 2 lists each 
family’s p-value and fold change.
We next examined the associations between host factors and microbiome abundance changes. Figure 3A plots 
Erysipelotrichaceae abundance difference before and after PrEP as a function of PrEP duration, age, race, TFV-DP 
WWS XNT WD5 WT9 XRQ 7RJ 5FX 7NR WWS XNT WD5 WT9 XRQ7RJ 5FX 7NR
80 %
60 %
40 %
20 %
0 %
Pre-PrEP Post-PrEP
suneGylimaF
Pre-PrEP Post-PrEP
A B
WWS XNT WD5 WT9 XRQ 7RJ 5FX 7NR WWS XNTWD5 WT9 XRQ 7RJ 5FX 7NR
Figure 1. Microbial abundance profiles before and after long-term PrEP with TDF-FTC. (A) Each family’s 
relative abundance within eight CCTG-595 study participants before and after PrEP. The microbiome profile 
was determined by MiSeq high-throughput sequencing of the V4 region of the 16s ribosomal RNA gene. 
Families were sorted by the empirical p-value from the permutation test. The level of Erysipelotrichaceae 
significantly increased with 48–72 weeks PrEP administration (p = 0.028). Streptococcaceae level significantly 
decreased after PrEP treatment (p = 0.039). (B) Each genus abundance for eight participants before and after 
PrEP, sorted by the permutation test p-value. The relative abundance of Streptococcus significantly decreased 
after PrEP treatment (permutation test, p = 0.036).
Figure 2. Erysipelotrichaceae and Streptococcus abundance changes by TDF-FTC. (A) The Erysipelotrichaceae 
abundance before and after PrEP for each of eight CCTG 595 study participants who were on daily PrEP for 48–72 
weeks. The average abundance of Erysipelotrichaceae was increased from 0.79% to 3.3%, resulting in a mean log2 
(fold change) of 2.1. Both permutation and paired-permutation tests indicate a statistically significant increase in 
the relative abundance of Erysipelotrichaceae after PrEP (p = 0.028 and p =0.031, respectively). (B) The Streptococcus 
abundance before and after PrEP for each of eight study participants. On average, the relative abundance of 
Streptocuccus was decreased from 12.0% to 1.2% after a minimum of 48 weeks PrEP treatment (permutation test 
p = 0.036 and paired-permutation test, p = 0.035). The resulting mean log2 (fold change) was −3.3.
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level, any drug use status and drug abuse status. The Erysipelotrichaceae change was not dependent on either PrEP 
duration (Spearman’s correlation ρ = 0.21 and p = 0.62) or age (ρ = 0.071 and p = 0.88). The abundance difference 
was not correlated with TFV-DP levels at 48 weeks after PrEP (ρ = −0.19 and p = 0.66). The Erysipelotrichaceae 
abundance difference was not sensitive to race (Kruskal-Wallis test, p = 0.37) and was not affected by any drug use 
(Wilcoxon rank sum test, p = 0.51) or drug abuse (Wilcoxon rank sum test, p = 1.0). Likewise, the Streptococcus 
change was not correlated with PrEP duration (ρ = 0.33 and p = 0.42). As shown in Fig. 3B, age was not associated 
with abundance change (ρ = 0.33 and p = 0.43). The abundance change was not sensitive to race (Kruskal-Wallis 
test, p = 0.11) and was not correlated with TFV-DP levels at 48 weeks after PrEP (ρ = 0.21 and p = 0.62). The 
Streptococcus abundance difference was not affected by any drug use (p = 0.64) or drug abuse (p = 0.39). This 
lack of significance of the differences might be due to the small sample size, however, Fig. 3 does not indicate any 
trends in the associations.
Figure 4 compares the family composition of eight individuals before and after PrEP. Consistent with pre-
vious reports on the healthy human gut microbiome profiles19,20, the CCTG 595 cohort was dominated by the 
phyla Bacteroidetes and Firmicutes. Prevotellaceae was the most dominant family in all specimens, except three 
pre-PrEP samples (XNT, 5FX, and 7RJ), with average abundance of 36% across all 16 specimens. Before the initia-
tion of PrEP, the most prevalent family in participant XNT and participant 5FX was Streptococcaceae with relative 
abundances of 51% and 17%, respectively. The most prevalent family in participant 7RJ prior to PrEP initiation 
was Fusobacteriaceae with 40% abundance. Across 16 specimens from eight participants, the average abundance 
of Lachnospiraceae (11%), Fusobacteriaceae (9.1%), Family_XI (8.8%), and Streptococcaceae (6.6%) were observed 
to be greater than five percent.
Each participant’s overall microbial diversity was comparable before and after PrEP. Microbiome diversity 
within a single specimen was assessed by α diversity, Shannon diversity index. The dissimilarity between a pair 
of specimens was assessed by β diversity which accounts for phylogenetic tree distances of microbial sequences 
in a pair of specimens. As shown in Fig. 5A, the average α diversity was 4.22 before PrEP and 4.95 after PrEP 
(Wilcoxon signed-rank test, p = 0.15). We plotted the β diversity of each participant’s paired specimens in Fig. 5B. 
Across 8 pairs, The average β diversity across 8 pairs was 0.68 and the paired specimens of the participant XRQ 
showed the lowest level of β diversity. The β diversity between each participant’s pre and post-PrEP specimens 
was smaller than the β diversity of pre-PrEP specimen pairs of different individuals (Wilcoxon rank sum test, 
p = 0.015). Principal coordinate analysis (PCoA) demonstrated that the pre-PrEP and post-PrEP specimens did 
not form distinct clusters (Fig. 5C). The principal coordinate analysis indicates that there is no global shift in the 
microbiota between the pre and post PrEP specimens. Individual family and genus abundance changes were 
Family
log2  
(fold change) p value Genus
log2  
(fold change) p value
Erysipelotrichaceae 2.08 0.028 Streptococcus −3.27 0.036
Streptococcaceae −3.27 0.039 Faecalibacterium 1.77 0.054
Ruminococcaceae 1.43 0.058 Catenibacterium 2.96 0.056
Comamonadaceae Inf 0.10 Roseburia 1.61 0.061
Lachnospiraceae 0.81 0.16 Dialister 1.77 0.062
Peptostreptococcaceae 1.16 0.17 Eubacterium_rectale_group 1.85 0.081
Alcaligenaceae −1.24 0.18 Coprococcus_2 −7.28 0.083
Fusobacteriaceae −1.02 0.18 Blautia 1.49 0.092
Actinomycetaceae 3.54 0.18 Ruminiclostridium_5 2.97 0.096
Acidaminococcaceae 1.00 0.19 Eubacterium_hallii_group 1.15 0.12
Corynebacteriaceae 1.51 0.20 Varibaculum 6.96 0.12
Enterobacteriaceae −3.66 0.21 Ruminococcus_2 1.63 0.13
Micrococcaceae Inf 0.24 Arcanobacterium 7.20 0.13
Enterococcaceae −4.59 0.27 Parvimonas 3.25 0.13
Pasteurellaceae −0.94 0.27 Haemophilus −3.52 0.13
Porphyromonadaceae 2.33 0.28 Coprococcus_3 1.35 0.14
Staphylococcaceae −2.34 0.28 Prevotella 1.23 0.14
Leptotrichiaceae 0.24 0.29 Peptoniphilus 1.14 0.15
Family_XI 0.41 0.30 Dorea 0.78 0.16
Veillonellaceae 0.33 0.35 Peptostreptococcus 1.31 0.16
Bifidobacteriaceae −0.55 0.36 Anaerovibrio −3.29 0.16
Carnobacteriaceae −0.40 0.39 Anaerococcus 1.07 0.16
Family_XIII −1.42 0.41 Corynebacterium_1 1.51 0.17
Bacteroidaceae −0.062 0.48 Sutterella −1.27 0.17
Prevotellaceae 0.022 0.48 Fusobacterium −1.02 0.17
Coriobacteriaceae −0.48 0.50 Ruminococcaceae_UCG-002 1.37 0.18
Table 2. Abundance difference in given family and genus before and after minimum 48 weeks of PrEP 
administration. The p value from the permutation test is presented.
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Figure 3. Microbiome changes after TDF-FTC and host factors. (A) Eight individuals’ Erysipelotrichaceae 
abundance differences before and after PrEP. The Erysipelotrichaceae abundance difference was not dependent 
on the duration of PrEP (Spearman’s correlation ρ = 0.21 and p = 0.62). Age did not significantly correlate with 
the Erysipelotrichaceae abundance change after PrEP (ρ = 0.071 and p = 0.88). The Erysipelotrichaceae abundance 
change was not sensitive to race (1 Asian vs. 1 Black vs. 4 Whites vs. 2 Multiples, Kruskal-Wallis test, p = 0.37) 
and was not correlated with intracellular tenofovir disphosphate level measured at 48 weeks after PrEP initiation 
(ρ = −0.19 and p = 0.66). The α-diversity abundance change did not differ between participants with and without 
any other drug use (Wilcoxon rank sum test, p = 0.51) and between participants with and without drug abuse 
(Wilcoxon rank sum test, p = 1.0) (B) The Streptococcus abundance change was not dependent on the duration of 
PrEP (Spearman’s correlation ρ = 0.33 and p = 0.42). Streptococcus change and age were not statistically correlated 
in the eight subjects (ρ = 0.33 and p = 0.43). Streptococcus abundance change was not sensitive to race (Kruskal-
Wallis test, p = 0.11) and was not correlated with the tenofovir diphosphate level at 48 weeks after PrEP (ρ = 0.21 and 
p = 0.62). The Streptococcus abundance change was not affected by any drug use (p = 0.64) or drug abuse (p = 0.39).
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inquired through permutation tests in this study, observing that Erysipelotrichaceae and Streptococcus levels were 
significantly shifted by PrEP.
Next we performed full-length 16S-23S rRNA long read sequencing to identify which species in Erysipelotrichaceae 
family and Streptococcus genus were affected by long-term PrEP. Figure 2 showed that participants XNT, 
WD5, WT9, XRQ, 7RJ, 5FX had changes in the abundance of either Erysipelotrichaceae or Streptococcus and 
from these participants, we obtained a total of 3363 reads of the 16S-23S rRNA region for species identification 
(Supplementary Table S2). Figure 6A compares the family composition of pre-PrEP and post-PrEP specimens for 
both v4–16S short read sequencing and 16S-23S long read sequencing. The overall family profiles were similar; 
the family composition root-mean-square-error between v4-16S and 16S-23S sequencings ranged from 0.016 
to 0.051 across each of 12 specimens from participants XNT, WD5, WT9, XRQ, 7RJ, 5FX. Observable differ-
ences in the microbiome profiles for the two sequencing methods were also present (Fig. 6A). We compared 
abundance changes in Erysipelotrichaceae and Streptococcus measured by v4-16S sequencing and 16S-23S long 
read sequencings (Fig. 6B). Post-PrEP Erysipelotrichaceae increase measured by 16S-23S sequencing was more 
prominent than that by v4-16S sequencing. Streptococcus decrease measured by 16S-23S sequencing was consist-
ent with that measured by v4-16S sequencing. Erysipelotrichaceae increase after PrEP was mainly driven by the 
species Catenibacterium mitsuokai. Holdemanella biformis and Turicibacter sanguinis were also detected within 
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Figure 4. The microbial family composition in eight individuals before and after TDF-FTC PrEP. Subjects are 
displayed in the pre-PrEP and post-PrEP panels from left to right as follows: WWS, XNT, WD5, WT9, XRQ, 
7RJ, 5FX, and 7NR. The phyla Bacteroidetes and Firmicutes were dominant in all 16 specimens. Prevotellaceae 
was the most abundant family in all specimens except three pre-PrEP specimens (XNT, 7FX, and 7RJ), with 
average abundance of 36%. Streptococcaceae was the most abundant family in pre-PrEP sample of participants 
XNT (51%) and 5FX (17%) and Fusobacteriaceae was the most abundant family in participant 7RJ’s pre-PrEP 
specimen (40%). The average relative abundance of Lachnospiraceae (11%), Fusobacteriaceae (9.1%), Family_XI 
(8.8%), and Streptococcaceae (6.6%) were observed to be greater than five percent across 16 specimens from 
eight participants.
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Figure 5. α diversity and β diversity. (A) Within specimen microbial diversity was measured by α-diversity 
(Shannon diversity index). Each participant’s pre-PrEP specimen’s α diversity is compared with post-PrEP 
specimen’s α diversity. The α diversity did not change significantly with PrEP treatment (Wilcoxon signed-
rank test, p = 0.15). (B) Microbial β diversity was measured between each participant’s pre and post specimens 
(8 pairs). The weighted UniFrac statistics were computed using QIIME43. (C) Microbial community variation 
was represented by principal coordinate analysis of weighted UniFrac distances among specimens. Specimen 
dissimilarities were projected onto the first three principal coordinate dimensions where pre-PrEP specimens 
are colored in blue and post-PrEP specimens are in red.
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this family (Fig. 6C). Before PrEP initiation, Streptococcus agalactiae, Streptococcus oralis, and Streptococcus mitis 
were the dominant species in the Streptococcus genus (Fig. 6D).
Discussion
PrEP use has increased substantially since 2012 and characterizing its long-term side effects is the first step to 
improve PrEP regimen and adherence1. Two well-known side effects of TDF are kidney function decline and bone 
mineral density decrease5,6. Recent studies reported that long-term PrEP users showed impaired kidney function3 
and a decrease in bone mineral density4. The human gut microbiota is known to be correlated with both chronic 
kidney disease and osteoporosis. Increases in uremic toxins and inflammation among chronic kidney disease 
patients were in part due to the gut microbiome’s role in the fermentation of short-chain fatty acids, which have 
an anti-inflammatory impact21. Intestinal bacterial overgrowth was associated with changes in essential metab-
olites for bone processes such as calcium, vitamin K, and vitamin B12. During a state of gut microbiome dysbi-
osis, gut microbiota can affect the absorption of calcium and vitamin D, which can lead to osteoporosis22. Our 
study profiled microbiome structures before and after long-term PrEP to identify microbiota signatures altered 
by TDF-FTC daily use, which have the potential to affect the kidney and bone health.
We observed that Streptococcus was significantly reduced from 12.0% to 1.2% and the Erysipelotrichaceae was 
significantly increased from 0.79% to 3.3% after a minimum of 48 weeks of daily PrEP among CCTG-595 study 
participants. This cohort is at high risk of HIV-1 infection and has extensive demographic and clinical details 
including PrEP adherence data. Both Streptococcus and Erysipelotrichaceae abundance changes were not asso-
ciated with host factors including PrEP duration, age, race, TFV-DP level, any drug use status and drug abuse 
status, suggesting that the observed microbiome shifts were potentially induced by daily TDF-FTC use.
Both commensal and pathogenic species of Streptococcus have been found to coexist in the healthy human 
gut microbiome23. Members of the Streptococcus genus have gut-protective influences. Streptococcus lactis, 
Streptococcus cremoris, and Streptococcus thermophilus are commonly found in both natural and commensal pro-
biotics24,25. Our 16S–23S long read sequencing revealed that Streptococcus agalactiae, Streptococcus oralis, and 
Streptococcus mitis were the closest species significantly greater in pre-PrEP specimens compared to post-PrEP 
specimens. Streptococcus agalactiae has been reported to be a harmless commensal bacterium, colonized in the 
intestine26. Streptococcus oralis and Streptococcus mitis are both commensal bacterial which predominately reside 
in the oral cavity27 but these species were also found in fecal samples28.
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Figure 6. Species identification using full-length 16S-23S sequencing. (A) Microbiome Family compositions 
measured by v4 region of 16s rRNA sequencing (left) and 16S-23S rRNA sequencing (right) for participants, 
XNT, WD5, WT9, XRQ, 7RJ, and 5FX at pre-PrEP and post-PrEP. (B) Abundance differences between pre-
PrEP and post-PrEP specimens for Erysipelotrichaceae (red) and Streptococcus (grey) for study participants, 
XNT, WD5, WT9, XRQ, 7RJ, and 5FX. The abundance difference of Erysipelotrichaceae measured by 16S-23S 
sequencing (filled red boxes) was increased in four individuals, compared to the abundance difference obtained 
from v4-16s sequencing (empty red boxes). The abundance difference of Streptococcus measured by 16S-23S 
sequencing (filled grey boxes) was consistent with that measured by v4-16s sequencing (empty grey boxes). (C) 
Species composition of Erysipelotrichaceae family measured from participants XNT, WD5, WT9, XRQ, 7RJ, and 
5FX after a minimum of 48 weeks PrEP. Within subjects XNT, WD5, WT9, and 5FX, Catenibacterium mitsuokai 
was the most dominant species in Erysipelotrichaceae family. Turicibacter sanguinis was detected in participant 
XRQ and Holdemanella biformis was detected in WD5 and WT9. (D) Species composition of Streptococcus 
genus measured from the above study participants before PrEP initiation. Streptococcus agalactiae (red) was 
most abundant in participant XNT, Streptococcus oralis (purple) was dominant in WD5, 7RJ and 5FX, and 
Streptococcus mitis (blue) was dominant in WT9.
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A common enteric side effect associated with TDF-FTC PrEP is a frequently cited reason for poor adherence 
to PrEP schedules29. However, this adverse effect, termed “PrEP start up syndrome”, is usually observed within the 
first month of TDF-FTC PrEP and resolves spontaneously by 3 months of treatment30,31. However, our post-PrEP 
specimens were collected 48–72 weeks after PrEP initiation. Therefore, a direct association between the enteric 
side effects and Streptococcus reduction should be further investigated at the time of PrEP start up syndrome. 
Additionally, the observed microbiota differences found using rectal swab specimens may not be comparable to 
those from other specimen types, collected from different gastrointestinal sites using mucosal biopsies32,33.
TDF-FTC also appeared to significantly increase the level of Erysipelotrichaceae, a family of bacteria that many 
species are considered opportunistic pathogens. Erysipelotrichaceae has been studied in conjunction with colorec-
tal cancer and metabolic disorders34. Erysipelotrichaceae was significantly enriched in patients with colorectal 
cancer, compared to healthy controls35. Similarly, an increase in Erysipelotrichaceae abundance was reported 
in colorectal tumor-bearing mice36. Additionally, Erysipelotrichaceae was increased in obese individuals37. Our 
long read sequencing showed that Catenibacterium mitsuokai, Holdemanella biformis and Turicibacter sanguinis 
were bacterial species increased after long-term PrEP within Erysipelotrichaceae family. Both Catenibacterium 
mitsuokai and Holdemanella biformis were associated with gut microbiome dysbiosis caused by high fat and 
high sugar diet38 and an unhealthy fasting lipid profile39. Collectively, we speculate that the observed increase in 
Erysipelotrichaceae in the long-term PrEP treated cohort has a potential to contribute to an increased the risk of 
colorectal cancer and metabolic disorders, while this increase was due to other factors including dietary factors. 
This speculation is worth further investigation with long-term follow-up of PrEP treated individuals.
In conclusion we observed that Streptococcus were decreased and Erysipelotrichaceae were increased follow-
ing daily TDF-FTC for PrEP. Because this study is limited by the small population size, these microbiome shifts 
should be further examined in a large cohort in conjunction with long-term outcomes. Identifying PrEP micro-
biota signatures is an important step toward treating and preventing side effects, which is likely to improve PrEP 
adherence, and thus HIV-1 prevention.
Methods
Study participants. Self-collected rectal swab specimens from eight individuals at baseline (pre-PreP) and 
after taking TDF-FTC daily for 48 to 72 weeks in the California Collaborative Treatment Group (CCTG) study 
595 (NCT01761643) were examined18. Participants were given a tube with a sterile Dacron rectal swab, along with 
safety precautions and instructions for rectal swab self-collection. The rectal swab was immediately placed in a 
sterile 15 ml plain conical tube without media, and the screw cap was secured. The tube containing the sample was 
transported to the laboratory at room temperature and frozen at −80 °C within two hours of collection. CCTG 
595 was a randomized controlled trial in high risk MSM and transgender women to compare the impact of daily 
text messaging to standard care on adherence to daily TDF-FTC18. Regimen adherence was assessed at 48 weeks 
by testing dried blood spots for tenofovir diphosphate (TFV-DP). This study included only participants with 
intracellular TFV-DP levels greater than 719 fmol/punch at week 48 weeks, a level associated with taking four or 
more doses of TDF a week40.
Alcohol and substance use were assessed using the SCID substance use screening questionnaire, DAST-10, 
and AUDIT questionnaires. None of the participants reported diarrhea. The participants’ dietary intake infor-
mation is not available, which can be an important factor for microbial composition. Six of eight participants 
reported rectal douching at baseline, one participant reported no use of rectal douching, and one participant 
declined to answer. All participants signed an informed consent document subject to approval at each site’s IRB 
(University of Southern California, University of California, San Diego, and Harbor-University of California, 
Los Angeles). All the procedures and experiments were conducted in accordance with relevant guidelines and 
regulations.
Microbiome DNA extraction. The previously frozen swabs were placed in a sterile 1.5 ml Eppendorf tube 
and the excess swab handle was removed using sterile razor blades or scissors. Microbiome DNA was extracted 
using the Omega Mag-Bind Universal Pathogen DNA Kit (OMEGA bio-tek). Glass beads, 700 µL of SLX-Mlus 
Buffer were added to the thawed swab specimen. After 1 minute of vortexing, the tube was centrifuged at 
1500 g for 5 minutes. 250 µL of the supernatant was collected, 275 µL SLX-Mlus Buffer was added, and heated to 
65 °C for 10 minutes and 95 °C for 10 minutes. Specimens were vortexed at maximum speed using a horizontal 
adapter (Qiagen) for 8 minutes. After the elution, specimens were purified and concentrated using a Clean & 
Concentrator-5 kit (Zymo Research). The sample concentration was measured using PicoGreen (Invitrogen).
16S ribosomal RNA sequencing. The next-generation sequencing library of the V4 region of the 16S rRNA 
gene was constructed by the following procedures. The extracted microbiome DNA was amplified using prim-
ers 515F-over (5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGCCAGCMGCCGCGGTAA-3′) 
and 805R-over (5′- GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3′) 
in a reaction volume of 20 µL (5 µL of 0.2 ng/ µL extracted DNA, 13 µL AccuStart II PCR ToughMix, 0.25 µL of 
20 µM 515F-over, 0.25 µL of 20 µM 805R-over and 1.5 µL nuclease-free water). The PCR condition was at 94 °C 
for 3 minutes, followed by 35 cycles of 94 °C for 30 seconds, 60 °C for 30 seconds, then 70 °C for 90 seconds 
with a final extension at 70 °C for 10 minutes. The PCR product was purified using Agencourt AMPure 
XP (Beckman Coulter). The index PCR was then performed using primers S5xx (5′-AATGATACGGCGACCA 
CCGAGATCTACACxxxxxxxxTCGTCGGCAGCGTC-3′) and N7xx (5′-CAAGCAGAAGACGGC 
ATACGAGATxxxxxxxxGTCTCGTGGGCTCGG-3′) in a reaction volume of 50 µL (4 µL of purified PCR prod-
uct, 25 µL AccuStart II PCR ToughMix, 16 µL nuclease-free water, 2.5 µL of 4 µM S5xx and 2.5 µL of 4 µM N7xx). 
The PCR condition was at 94 °C for 3 minutes, followed by 8 cycles of 94 °C for 30 seconds, 45 °C for 30 seconds, 
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70 °C for 120 seconds and 10 cycles of 94 °C for 30 seconds, 60 °C for 30 seconds, 70 °C for 120 seconds with a 
final extension at 70 °C for 10 minutes. The PCR product was purified using Agencourt AMPure Xp (Beckman 
Coulter). Each sample concentration was determined using PicoGreen (Invitrogen), normalized and pooled 
and sent to the University of California, Los Angeles Technology Center for Genomics and Bioinformatics for 
Illumina MiSeq sequencing.
16S–23S ribosomal RNA sequencing. We performed 16S-23S rRNA long read sequencing on pre-PrEP 
and post-PrEP specimens from participants XNT, WD5, WT9, XRQ, 7RJ, 5FX. Additionally, a microbiome stand-
ard (ATCC, MSA-1001) consisting of 10 control strains was sequenced. Each participant’s extracted microbi-
ome DNA (as described above) was amplified using primers 27F (5′-AGAGTTTGATCMTGGCTCAG-3′) and 
2409R23 (5′-GACATCGAGGTGCCAAAC-3′), targeting around 4500 base long 16S-23S rRNA region. PCR 
was performed in a reaction volume of 20 µL (5 µL of 0.2 ng/ µL extracted DNA, 13 µL of 2x AccuStart II PCR 
ToughMix, 1.5 µL nuclease-free water, 0.25 µL of 20 µM 27 F and 0.25 µL of 20 µM 2409R23). The PCR condition 
was 94 °C for 3 minutes, 35 cycles of 94 °C for 30 seconds, 60 °C for 30 seconds, 70 °C for 5 minutes, and a final 
extension at 70 °C for 10 minutes. The PCR product was purified with 1.8x Ampure XP Beads, washed twice with 
70% ethanol, and eluted in 20 µL of nuclease free water.
The purified samples were then set up for an index PCR to barcode each sample using primers, 27Fxx 
(5′-xxxxxxxxxxxxAGAGTTTGATCMTGGCTCAG-3′) and 2409R23xx (5′-xxxxxxxxxxxxGACATC 
GAGGTGCCAAAC-3′). The index PCR was performed in a 50 µL reaction volume with 5 µL of purified PCR 
product, 25 µL AccuStart II PCR ToughMix, 17.6 µL nuclease-free water, 1.2 µL of 4 µM 27Fxx and 1.2 µL of 4 µM 
2409R23xx. The PCR condition was at 94 °C for 3 minutes, followed by 10 cycles of 94 °C for 30 seconds, 63 °C for 
20 seconds, 70 °C for 5 minutes, and a final extension at 70 C for 10 minutes. The index PCR condition for spec-
imen pre-PrEP 5FX was modified by increasing primer volumes (2.5 µL), increasing the purified PCR product 
volume (7 µL), lowering the annealing temperature (60 °C), and increasing annealing time (60 °C for 30 seconds).
A PicoGreen assay was performed to determine the concentration of each sample. Equimolar amounts of 
each of 13 samples were pooled and shipped overnight on dry ice to RTL genomics for PacBio sequencing. 
After arrival, the samples were checked for concentration using the dsDNA Broad Range DNA kit on the Qubit 
Fluorometer 3.0 and quality checked with a Fragment Analyzer by Advanced Analytical Technologies using the 
High Sensitivity Large Fragment 50KB Analysis kit, which were subject to SMRTbell library preparation for 
PacBio Sequencing. This process began with a 0.5x Ampure PB Purification A total of 600 ng of DNA was used 
for creating circularized double stranded DNA templates by ligating hairpin adaptors to each side of templates. 
Following the overnight ligation, the circular templates were purified with AMPure PB Beads and SMRTbell 
sequencing primers were annealed to the adaptors. The dsDNA templates were then prepared for loading with a 
final concentration of 6 pM to initiate SMRTbell template sequencing.
Sequence data analysis. The forward and reverse reads obtained from the MiSeq sequencing run were 
assembled using the command, make.contigs in MOTHUR41. The obtained fasta file was screened for the presence 
of ambiguous bases and any reads with such bases were discarded. The reads were then subjected to taxonomy 
annotation after putative chimeric sequences were removed using chimera.uchime. The Silva full length sequences 
and taxonomy references, consisting of 190,661 sequences (release 128), were used for taxonomy annotation42. 
To expedite taxonomy annotation, clustering was performed using pre.cluster by grouping reads that are within 
one mismatch of each other. Supplementary Table S1 shows the number of total reads and unique reads, prior to 
processing and post processing for each of the 16 specimens sequenced in this study.
Each read obtained from a 16S-23S rRNA sequencing run was subjected to taxonomy annotation after remov-
ing putative chimeric sequences and clustering. BLAST with NCBI nucleotide collection database was used to 
find the bacterial species with the best match for each read. When the best matched strain showed less than 90% 
identity or the length of the best matched strain was less than 25% of each read length, the read was labeled as 
unclassified.
Each specimen’s α diversity with the Shannon diversity index was measured using alpha_diversity.py in 
QIIME43. To calculate β diversity, all 16 specimens’ fasta files were combined as a single file. Closely related 
sequences with similarities greater than 97% were grouped as an operational taxonomic unit (OTU) using pick_
otus.py in QIIME and each OTU’s representative sequence was picked using pick_rep_set.py. The selected rep-
resentative sequences were aligned using align_seqs.py with the MUSCLE algorithm. Then the OTU table and 
phylogenetic tree were obtained using make_otu_table.py and make_phylogeny.py, respectively. Using QIIME 
jackknifed_beta_diversity.py, jackknife resampling was performed by sampling 1% of the total sequences and 
repeated 10 times to obtain specimen pair’s β diversity matrices and principal coordinate analysis (PCoA) plots.
Permutation t test. We statistically examined differences in family or genus abundance between pre-PrEP 
and post-PrEP specimens. The standard t-tests for paired measurements assume independence, normality, and 
constant variance. With abundance proportions, it is likely that normality and constant variance are not held and 
the sample size is not large enough to use approximate normality of the mean. Instead, we conducted a permu-
tation test in order to empirically assess the asymptotic p-values. The permutation test has been widely recom-
mended in multiple statistical testing44–46. For each family or genus, a t-statistic was computed on the observed 
diversity data as follows:
=
−
+
t POST PRE
POST Pre n( )/
,
(1)
av av
var var
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where n is the number of participants, POSTav (PREav) is the average abundance of a given family or genus among 
post-PrEP (pre-PrEP) specimens, and POSTvar (PREvar) is the abundance variance of a given family or genus 
among post-PrEP (pre-PrEP) specimens. The PrEP status was then randomly permuted, holding the numbers 
of pre-PrEP and post-PrEP specimens constant over permutations; a total of 100,000 such permutations were 
completed. A t-statistic in Eq. (1) was computed for each permutation and the empirical p-value of each family 
or genus was calculated as the proportion of permutations with a t-test statistic greater than or equal to the t-test 
statistic derived from the actual data when the original t value was greater than zero. Otherwise, the empiric 
p-value was determined as the proportion of permutations with a t-test statistic less than or equal to the negative 
original t value. Based on this empirical p-value, the families or genera with significant differences in abundance 
between pre-PrEP and post-PrEP were determined. We also performed paired permutation tests for a given fam-
ily or genus where we permuted each participant’s pre-PrEP and post-PrEP abundance values, yielding a total of 
2n permutations. For each permutation, a t-statistic was measured and the empirical p-value was obtained from 
the proportion of permuted t-statistics that were more extreme than the observed data t-statistic.
Data Availability
All microbiome sequence data from this study are available at EBI with accession numbers PRJEB29018 and 
PRJEB29019.
References
 1. Rawlings, K. M. S. In International AIDS Conference (Durban, South Africa, 2016).
 2. Grant, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363, 
2587–2599 (2010).
 3. Gandhi, M. et al. Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on 
pre-exposure prophylaxis: an observational cohort study. Lancet HIV 3, e521–e528 (2016).
 4. Mulligan, K. et al. Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-
Blind, Placebo-Controlled Trial. Clin Infect Dis 61, 572–580 (2015).
 5. Tourret, J., Deray, G. & Isnard-Bagnis, C. Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword? J Am 
Soc Nephrol 24, 1519–1527 (2013).
 6. Stellbrink, H. J. et al. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine 
in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis 51, 963–972 (2010).
 7. Kohler, J. J. et al. Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters. Lab Invest 91, 
852–858 (2011).
 8. Grigsby, I. F. et al. Tenofovir treatment of primary osteoblasts alters gene expression profiles: implications for bone mineral density 
loss. Biochemical and biophysical research communications 394, 48–53 (2010).
 9. Casado, J. L. et al. Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-
infected patients. AIDS 30, 1423–1431 (2016).
 10. Wong, J. et al. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-
producing intestinal microbiota in ESRD. Am J Nephrol 39, 230–237 (2014).
 11. Yan, J. et al. Gut microbiota induce IGF-1 and promote bone formation and growth. P Natl Acad Sci USA 113, E7554–E7563 (2016).
 12. Chen, Y. C., Greenbaum, J., Shen, H. & Deng, H. W. Association Between Gut Microbiota and Bone Health: Potential Mechanisms 
and Prospective. J Clin Endocr Metab 102, 3635–3646 (2017).
 13. Yocum, R. R., Rasmussen, J. R. & Strominger, J. L. The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus 
stearothermophilus D-alanine carboxypeptidase. J Biol Chem 255, 3977–3986 (1980).
 14. Smieja, M. Current indications for the use of clindamycin: A critical review. Can J Infect Dis 9, 22–28 (1998).
 15. Tenson, T., Lovmar, M. & Ehrenberg, M. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the 
nascent peptide exit path in the ribosome. Journal of Molecular Biology 330, 1005–1014 (2003).
 16. van der Waaij, D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium 
difficile. Annu Rev Microbiol 43, 69–87 (1989).
 17. Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).
 18. Moore, D. J. et al. Randomized Controlled Trial of Daily Text Messages To Support Adherence to PrEP In At-Risk for HIV 
Individuals: The TAPIR Study. Clin Infect Dis 66, 1566–1572 (2017).
 19. Huttenhower, C. et al. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
 20. Hollister, E. B., Gao, C. X. & Versalovic, J. Compositional and Functional Features of the Gastrointestinal Microbiome and Their 
Effects on Human Health. Gastroenterology 146, 1449–1458 (2014).
 21. Armani, R. G. et al. Gut Microbiome in Chronic Kidney Disease. Curr Hypertens Rep 19, 29 (2017).
 22. Xu, X. et al. Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis. Bone Res 5, 17046 (2017).
 23. Cook, L. C., LaSarre, B. & Federle, M. J. Interspecies Communication among Commensal and Pathogenic Streptococci. Mbio 4, 
e00382–13 (2013).
 24. Kaci, G. et al. Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive 
tract. Appl Environ Microbiol 80, 928–934 (2014).
 25. de Roos, N. M. & Katan, M. B. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers 
published between 1988 and 1998. Am J Clin Nutr 71, 405–411 (2000).
 26. Ryan, K. J. et al. Sherris Medical Microbiology (4th ed.). McGraw Hill. 286–8 (2004).
 27. Reichmann, P. et al. Genome of Streptococcus oralis strain Uo5. Journal of bacteriology 193, 2888–2889 (2011).
 28. Kinumaki, A. et al. Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front Microbiol 6, 
824 (2015).
 29. Van der Elst, E. M. et al. High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative 
Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya. Aids and Behavior 17, 2162–2172 
(2013).
 30. Mugwanya, K. K. & Baeten, J. M. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention. 
Expert Opin Drug Saf 15, 265–273 (2016).
 31. Glidden, D. V. et al. Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. Clin Infect Dis 62, 1172–1177 (2016).
 32. Araujo-Perez, F. et al. Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes 3, 
530–535 (2012).
 33. Hanshew, A. S., Jette, M. E., Tadayon, S. & Thibeault, S. L. A comparison of sampling methods for examining the laryngeal 
microbiome. PLoS One 12, e0174765 (2017).
 34. Kaakoush, N. O. Insights into the Role of Erysipelotrichaceae in the Human Host. Front Cell Infect Micro 5, 84 (2015).
www.nature.com/scientificreports/
1 1SCIeNtIfIC REPoRTS |  (2018) 8:15212  | DOI:10.1038/s41598-018-33524-6
 35. Chen, W. G., Liu, F. L., Ling, Z. X., Tong, X. J. & Xiang, C. Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients 
with Colorectal Cancer. Plos One 7, e39743 (2012).
 36. Zackular, J. P. et al. The Gut Microbiome Modulates Colon Tumorigenesis. Mbio 4, e00692–13 (2013).
 37. Zhang, H. et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106, 2365–2370 (2009).
 38. Duda-Chodak, A., Tarko, T., Satora, P. & Sroka, P. Interaction of dietary compounds, especially polyphenols, with the intestinal 
microbiota: a review. Eur J Nutr 54, 325–341 (2015).
 39. Brahe, L. K. et al. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diabetes 5, 
e159 (2015).
 40. Castillo-Mancilla, J. R. et al. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and 
cumulative drug exposure. AIDS Res Hum Retroviruses 29, 384–390 (2013).
 41. Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and 
comparing microbial communities. Appl Environ Microbiol 75, 7537–7541 (2009).
 42. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 
41, D590–596 (2013).
 43. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335–336 (2010).
 44. Camargo, A., Azuaje, F., Wang, H. & Zheng, H. Permutation - based statistical tests for multiple hypotheses. Source Code Biol Med 
3, 15 (2008).
 45. Dudoit, S., Shaffer, J. P. & Boldrick, J. C. Multiple hypothesis testing in microarray experiments. Stat Sci 18, 71–103 (2003).
 46. Nakagawa, S. A farewell to Bonferroni: the problems of low statistical power and publication bias. Behav Ecol 15, 1044–1045 (2004).
Acknowledgements
This work was supported by NIH grants R01 AI095066 and AI083115 (to HYL) and by EI-11-SD-005 from the 
California HIV/AIDS Research Program (to SRM). We thank the CCTG 595 study participants. We thank Sharon 
Chang and Kelli Brooks for providing help in sequencing and William DePaolo, Wendy Mack and Emily Johnson 
for helpful discussions. We thank the University of California, Los Angeles Technology Center for Genomics and 
Bioinformatics and RTL genomics.
Author Contributions
M.P.D., S.Y.P., H.R. and H.Y.L. designed the study, performed sequencing and conducted bioinformatics analyses. 
M.P.D. and S.R.M. chose the study cohort and complied clinical data of the study participants. S.Y.P., H.Y.L. and 
T.L. performed sequence analysis and statistical testing. All authors participated in the writing of the manuscript. 
All authors read and approved the final manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-33524-6.
Competing Interests: M.P.D. has served as a consultant to Gilead Sciences, Astra Zeneca and 
Theratechnologies, and has received research funding paid to his University from Gilead Sciences, ViiV, and 
Theratechnologies. All other authors: No reported conflicts of interest.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
